BRIEF-Invion Ltd announces collaboration with 3M for respiratory franchise

Wed, 19 Feb - 8:47am

Feb 19 (Reuters) - Invion Ltd IVX.AX :

* Collaboration with 3M for respiratory franchise

* Says agreement will assess the feasibility of inhaled versions of two respiratory drug assets - inv102 (nadolol) and inv104 (zafirlukast)

* Source text for Eikon News Search ID:nASX560w7F

((For more news, please click here IVX.AX ))

((Bangalore Newsroom; +91 80 6749 1130))

URN:

urn:newsml:reuters.com:20140218:nWNBS00BVH:6

Topics:

DEAL1 LEN RTRS BACT AU CMPNY PHMR HECA MRCH BLR ASIA

Public links